257. Hepatic glycogenosis Clinical trials / Disease details
Clinical trials : 14 / Drugs : 27 - (DrugBank : 7) / Drug target genes : 3 - Drug target pathways : 8
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02448667 (ClinicalTrials.gov) | January 2015 | 15/5/2015 | Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies | Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies | Glycogen Storage Disease Type III | Dietary Supplement: FAXE Kondi;Dietary Supplement: Faxe Kondi Free | Rigshospitalet, Denmark | NULL | Recruiting | 18 Years | N/A | All | 15 | N/A | Denmark |